Journey Medical Net Income

The latest net income for DERM is $-6.1M as of June 2026. That compares with $-8.7M in the prior-year period — up 30.1% year over year. That is below the sector sector average of $86M. Investors often review this figure alongside Journey Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, DERM's net income moved from $-8.7M to $-6.1M — a 30.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Journey Medical's operating scale or balance-sheet position.

Against its sector companies, DERM currently prints $-6.1M for net income, while the sector average sits near $86M. That is roughly 107.1% below the sector mean. Large gaps often invite a closer look at Journey Medical's growth, margins, and balance sheet.

A net income figure of $-6.1M for DERM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $86M. Explore the charts below for those layers of context.

After noting DERM's net income ($-6.1M), review year-over-year change from $-8.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.